Online First »

FDA Approves New Combination Therapy for Type 2 Diabetes

The FDA has approved the combination dapagliflozin and metformin oral once-daily tablet for the treatment of type 2 diabetes. It is the first combination of metformin and a sodium-glucose cotransporter 2 for the treatment of diabetes. Dapagliflozin/metformin is manufactured by AstraZeneca.—Kerri Fitzgerald

 


Online Exclusive »

Less Than Half of Doctors in Insurance Directories May be Available

(Reuters Health) - More than half the dermatologists in Medicare Advantage plan directories were either dead, retired, not accepting new patients or specialized only in specific conditions, researchers found when they tried making appointments.

Inaccurate directories of doctors covered by an insurance plan may lead to people having very few options and to the U.S. government approving plans that don’t meet standards regarding provider availability, the study team writes in JAMA Dermatology.


Current Issue

Cover Story; American Academy of Pain Management »

States, Federal Government Debate Use of Medical Marijuana

Phoenix—As a clinical pharmacy specialist at the Stratton Veterans Affairs Medical Center in Albany, New York, Jeffrey Fudin, PharmD, is prohibited from prescribing or dispensing marijuana. He is a federal government employee and must abide by US law that makes marijuana illegal.